Sky Investment Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20,438
Closed -$678K 127
2023
Q3
$678K Sell
20,438
-4,289
-17% -$152K 0.15% 88
2023
Q2
$907K Sell
24,727
-1,750
-7% -$68.1K 0.2% 83
2023
Q1
$1.08M Sell
26,477
-322
-1% -$13.9K 0.25% 78
2022
Q4
$1.37M Buy
26,799
+347
+1% +$16.6K 0.32% 74
2022
Q3
$1.16M Buy
26,452
+1,262
+5% +$61.3K 0.3% 72
2022
Q2
$1.32M Hold
25,190
0.32% 72
2022
Q1
$1.3M Buy
25,190
+65
+0.3% +$3.37K 0.28% 74
2021
Q4
$1.48M Sell
25,125
-200
-0.8% -$9.91K 0.3% 74
2021
Q3
$1.09M Hold
25,325
0.24% 81
2021
Q2
$992K Sell
25,325
-200
-0.8% -$7.78K 0.22% 81
2021
Q1
$925K Buy
25,525
+5,569
+28% +$198K 0.22% 81
2020
Q4
$735K Sell
19,956
-76
-0.4% -$2.79K 0.19% 84
2020
Q3
$698K Buy
+20,032
New +$702K 0.19% 82

Other funds holding PFE

Sky Investment Group's PFE Position: Q4 2023 in Review

Sky Investment Group sold out of Pfizer (PFE) in Q4 2023, closing a stake of 20,438 shares — an estimated $678K sold.

Sky Investment Group first reported a position in PFE in Q3 2020 and held it in 13 quarters. The position peaked at $1.48M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Sky Investment Group reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Sky Investment Group sold 20,438 Pfizer shares in Q4 2023, an estimated $678K.
  • Sky Investment Group first reported a position in Pfizer in Q3 2020 and held it in 13 quarters.
  • Sky Investment Group's Pfizer position peaked at $1.48M in Q4 2021.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Sky Investment Group's 13F filing for Q4 2023, filed 24 Jan 2024.